Andrew Hessel is the Co-Chair of biotechnology and bioinformatics at Singularity University, an educational institution created to train leaders in exponential (fast-changing) technologies. He views living cells as powerful information processors that are programmable with genetic engineering. His personal focus is synthetic biology, a suite of tools that allow genomes to be manipulated with relative ease. Andrew is also the co-founder and managing director of the Pink Army Cooperative, a social biotechnology company working to create open source personalized breast cancer treatments.